EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mucopolysaccharidosis Type II Screening, Diagnosis, and Management: A Literature Review and Practical Recommendations for Newborn Screening Programs and Health Care Providers to Support Families and Improve Outcomes

Amy Gaviglio iD, Natasha Bonhomme iD, Barbara Burton, Norman Matthew Ellinwood iD, Joseph Muenzer, Kim Stephens iD, Ravi Pathak, Carolyn Schaeffer-Koziol iD

International Journal of Neonatal Screening · 12.08.2026 · 12 (3) · 66

DOI: 10.3390/ijns12030066 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 12.08.2026. Verfasst von Amy Gaviglio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Connetics Consulting LLC, Minneapolis, MN 55417, USA. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Pharmaceuticals U.S.A., Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidosis type II (MPS II; also known as Hunter syndrome), is a rare X-linked lysosomal disease that leads to progressive tissue and organ damage. Early treatment is essential as most symptoms of MPS II are not reversible. Consequently, MPS II has been added to many newborn screening (NBS) programs. This narrative literature review provides practical recommendations from a multidisciplinary expert panel on the US-based NBS for MPS II and its diagnosis and clinical management. Recommendations for NBS programs include aiming for universal access to NBS within their jurisdiction, implementing tiered testing to support diagnostic accuracy, and providing infrastructure for confirmatory testing and post-screening support for families. Recommendations for health care providers (HCPs) include communicating test results empathetically and alongside verbal and written information, allowing families to express their feelings, and consulting an MPS II specialist to support treatment recommendations. The NBS programs and HCPs should work together to ensure positive screening results are communicated effectively and to provide equitable access to treatment and long-term care. Such a coordinated and appropriately resourced effort involving NBS programs, HCPs, and patient advocates will ensure better support for families and the best possible outcomes for individuals with MPS II.

Schlagwörter

Stichwörter der Autor:innen

Hunter syndromeMPS IINBSmucopolysaccharidosis type IInewborn screening programrare diseases

Autor:innen und Institutionen

  • Connetics Consulting LLC, Minneapolis, MN 55417, USA.
  • Expecting Health, Washington, DC 20016, USA.
  • Edwards Family Division of Genetics and Rare Diseases at Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
  • Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
  • National MPS Society, Durham, NC 27709-4686, USA.
  • University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, USA.

ORCID-Profile: Amy Gaviglio, Natasha Bonhomme, Norman Matthew Ellinwood, Kim Stephens, Carolyn Schaeffer-Koziol

Förderung

  • Takeda Pharmaceuticals U.S.A., Inc.

Zitieren

APA

Gaviglio, A., Bonhomme, N., Burton, B., Ellinwood, N. M., Muenzer, J., Stephens, K., Pathak, R., & Schaeffer-Koziol, C. (2026). Mucopolysaccharidosis Type II Screening, Diagnosis, and Management: A Literature Review and Practical Recommendations for Newborn Screening Programs and Health Care Providers to Support Families and Improve Outcomes. International Journal of Neonatal Screening, 12(3), 66. https://doi.org/10.3390/ijns12030066

Vancouver

Gaviglio A, Bonhomme N, Burton B, Ellinwood NM, Muenzer J, Stephens K, et al. Mucopolysaccharidosis Type II Screening, Diagnosis, and Management: A Literature Review and Practical Recommendations for Newborn Screening Programs and Health Care Providers to Support Families and Improve Outcomes. International Journal of Neonatal Screening. 2026;12(3):66. doi:10.3390/ijns12030066

BibTeX
@article{Gaviglio2026,
  author = {Gaviglio, Amy and Bonhomme, Natasha and Burton, Barbara and Ellinwood, Norman Matthew and Muenzer, Joseph and Stephens, Kim and Pathak, Ravi and Schaeffer-Koziol, Carolyn},
  title = {Mucopolysaccharidosis Type II Screening, Diagnosis, and Management: A Literature Review and Practical Recommendations for Newborn Screening Programs and Health Care Providers to Support Families and Improve Outcomes},
  journal = {International Journal of Neonatal Screening},
  year = {2026},
  volume = {12},
  number = {3},
  pages = {66},
  doi = {10.3390/ijns12030066}
}
Kostenlos starten →